scholarly journals Two dimensions of social anxiety disorder: a pilot study of the Questionnaire for Social Anxiety and Social Competence Deficits for Adolescents

Author(s):  
Carolin Fernandez Castelao ◽  
Katharina Naber ◽  
Stefanie Altstädt ◽  
Birgit Kröner-Herwig ◽  
Uwe Ruhl
2013 ◽  
Vol 38 (2) ◽  
pp. 226-238 ◽  
Author(s):  
Anu Asnaani ◽  
Mike Rinck ◽  
Eni Becker ◽  
Stefan G. Hofmann

CNS Spectrums ◽  
2002 ◽  
Vol 7 (9) ◽  
pp. 655-657 ◽  
Author(s):  
Naomi M. Simon ◽  
Nicole B. Korbly ◽  
John J. Worthington ◽  
Gustavo Kinrys ◽  
Mark H. Pollack

ABSTRACTThere is limited systematic data assessing alternate pharmacotherapy of social anxiety disorder in patients failing to tolerate or fully respond to initial treatment; no data specifically address the efficacy of citalopram in this scenario. We present a prospective open-label trial of citalopram in 10 patients with generalized social anxiety disorder, 6 of 10 of whom had not responded to or not tolerated a prior treatment intervention for the disorder. Citalopram, at a mean dose of 55 mg (SD+12.7 mg) was well tolerated, and patients improved significantly on all outcome measures. Results of this study suggest that citalopram may be a safe and effective treatment for generalized social anxiety disorder, including patients who have failed to tolerate or respond to a prior treatment trial.


2010 ◽  
Vol 83 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Bernet M. Elzinga ◽  
Philip Spinhoven ◽  
Ed Berretty ◽  
Paula de Jong ◽  
Karin Roelofs

Sign in / Sign up

Export Citation Format

Share Document